Matthew Cohen
Net worth: 925 727 $ as of 31/05/2026
Net worth: 925 727 $ as of 31/05/2026
Matthew G.
Cohen is currently the Managing Director at VV Manager LLC since 2025 and Director at Arrowhead Pharmaceuticals, Inc. since 2026.
Formerly, Dr. Cohen was a Portfolio Manager at JPMorgan Investment Management, Inc. from 2005 to 2025 and a Healthcare Analyst at Narragansett Asset Management LLC in 2003.
Education includes graduate studies at McGill University and an MBA from New York University, conferred in 2001.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/06/2026 | 11,882 ( 0.01% ) | 925 727 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 12/06/2026 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Private Equity Investor | 02/04/2025 |
| Companies | Position | End |
|---|---|---|
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Analyst-Equity | 11/02/2025 |
Narragansett Asset Management LLC
Narragansett Asset Management LLC Investment ManagersFinance Narragansett Asset Management employs a fundamental value-added research approach and adheres to a long-term investment horizon. The firm invests in equities, debt, commodities and currencies, depending on the current investment climate. | President | 27/02/2003 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Finance |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Narragansett Asset Management LLC
Narragansett Asset Management LLC Investment ManagersFinance Narragansett Asset Management employs a fundamental value-added research approach and adheres to a long-term investment horizon. The firm invests in equities, debt, commodities and currencies, depending on the current investment climate. | Finance |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Select your edition
All financial news and data tailored to specific country editions